Arkolith/Insider Trading/ABCL/Form 4

Booth Andrew

Chief Financial OfficerAbCellera Biologics Inc. (ABCL) · full profile →Form 4 · filed Dec 22, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 20, 2022Gift(G)50K—$0139K
Dec 20, 2022Option exercise(M)50K$0.19$10K189K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 20, 2022Option exercise(M)50K—$05.8M

Transaction Codes

G
Gift
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-062412) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML